Aptabridge Therapeutics Email Formats

Biotechnology Research • Baltimore, Maryland, United States • 1-10 Employees

Aptabridge Therapeutics Email Formats

Aptabridge Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@aptabridge.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@aptabridge.com	100%

Key Contact at Aptabridge Therapeutics

Julie Clauss

Chief Executive Officer

Company overview

Headquarters	Baltimore, Maryland, United States
Website	aptabridge.com
Founded	2021
Employees	1-10
Socials

About Aptabridge Therapeutics

Aptabridge Therapeutics, Inc. is creating next generation immunotherapies to tackle areas of high unmet medical need. We are developing a computationally driven drug design pipeline to rapidly develop immune modulators with favorable safety profiles. Our team is made of driven biotechnology experts who are driven to improve the outcomes of patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Aptabridge Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Aptabridge Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-06-02	9	$3,000

Funding Insights

$3,000

Total funding amount

$3,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Aptabridge Therapeutics is located in Baltimore, Maryland, US.

Aptabridge Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Aptabridge Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Aptabridge Therapeutics has raised a total of $3,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Aptabridge Therapeutics

Julie Clauss

Chief Executive Officer

4.8

40,000 users